Abstract:Background: The relationship between gut microbiota and hematologic malignancies has attracted considerable attention. As research progresses, it has become increasingly clear that the composition of gut microbiota may influence the onset and progression of hematologic malignancies. However, our understanding of this association remains limited. Methods: In our study, we classified gut microbiota into five groups based on information at the phylum, class, order, family, and genus levels. Subsequently, we obtained data related to common hematologic malignancies from the IEU Open GWAS project. We then employed a bidirectional Mendelian Randomization (MR) approach to determine whether there is a causal relationship between gut microbiota and hematologic malignancies. Additionally, we conducted bidirectional MR analyses to ascertain the directionality of this causal relationship. Results: Through forward and reverse MR analyses, we found the risk of lymphoid leukemia was significantly associated with the abundance of phylum Cyanobacteria, order Methanobacteriales, class Methanobacteria, family Peptococcaceae, family Methanobacteriaceae, and genera Lachnospiraceae UCG010, Methanobrevibacter, Eubacterium brachy group, and Butyrivibrio. The risk of myeloid leukemia was significantly associated with the abundance of phylum Actinobacteria, phylum Firmicutes, order Bifidobacteriales, order Clostridiales, class Actinobacteria, class Gammaproteobacteria, class Clostridia, family Bifidobacteriaceae, and genera Fusicatenibacter, Eubacterium hallii group, Blautia, Collinsella, Ruminococcus gauvreauii group, and Bifidobacterium. The risk of Hodgkin lymphoma was significantly associated with the abundance of family Clostridiales vadinBB60 group, genus Peptococcus, and genus Ruminococcaceae UCG010. The risk of malignant plasma cell tumor was significantly associated with the abundance of genera Romboutsia and Eubacterium rectale group. The risk of diffuse large B-cell lymphoma was significantly associated with the abundance of genera Erysipelatoclostridium and Eubacterium coprostanoligenes group. The risk of mature T/NK cell lymphomas was significantly associated with the abundance of phylum Verrucomicrobia, genus Ruminococcaceae UCG013, genus Lachnoclostridium, and genus Eubacterium rectale group. Lastly, the risk of myeloproliferative neoplasms was significantly associated with the abundance of genus Coprococcus 3 and Eubacterium hallii group. Conclusion: Our study provided new evidence for the causal relationship between gut microbiota and hematologic malignancies, offering novel insights and approaches for the prevention and treatment of these tumors.

The causal relationship between gut microbiota and lymphoma: a two-sample Mendelian randomization study

Causal relationships between gut microbiota and lymphoma: a bidirectional Mendelian randomization study

The causal relationship between gut microbiota and end-stage liver disease: a bidirectional Mendelian randomization analysis

Causal relationships of gut microbiota, plasma metabolites, and metabolite ratios with diffuse large B-cell lymphoma: a Mendelian randomization study

The causality between gut microbiota and non-Hodgkin lymphoma: a two-sample bidirectional Mendelian randomization study

Causal Associations Between the Gut Microbiota and Multiple Myeloma: a Two-Sample Mendelian Randomization Study

Refining the relationship between gut microbiota and common hematologic malignancies: insights from a bidirectional Mendelian randomization study

Exploring the causal relationship between gut microbiota and multiple myeloma risk based on Mendelian randomization and biological annotation

Dissecting Causal Links Between Gut Microbiota, Inflammatory Cytokines, and DLBCL: A Mendelian Randomization Study

Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites

Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study

Causal relationship between gut microbiota and gynecological tumor: a two-sample Mendelian randomization study

Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study

Gut Microbiota's role in lipoma development: evidence from mendelian randomization

Causal relationships between gut microbiota, immune cell, and Non-small cell lung cancer: a two-step, two-sample Mendelian randomization study

Association between gut microbiota and gastrointestinal cancer: a two-sample bi-directional Mendelian randomization study

Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study

Causal associations between gut microbiota and cutaneous melanoma: a Mendelian randomization study

Causal effects of gut microbiota in the development of lung cancer and its histological subtypes: A Mendelian randomization study

Association between gut microbiota and gastric cancers: a two-sample Mendelian randomization study

Causality between gut microbiota, immune cells, and breast cancer: Mendelian randomization analysis